En este evento académico, los médicos especialistas tendrán la oportunidad de conocer e intercambiar acerca de los tratamientos anticoagulantes en fibrilación auricular no valvular. Con foco en la innovación y en mejorar la calidad de vida de los pacientes, Bayer también se enorgullece de promover prácticas y tecnologías Web 3.0 innovadoras como NFT POAPs. Este es el primer POAP NFT en Bolivia y tercero en el mundo relacionado con un producto farmacéutico. Si recibió este POAP, usted es un verdadero pionero en el espacio Web 3.0. Por favor lea los términos y condiciones de Bayer POAPs en el siguiente enlace: https://bayer.com/poap Para más información sobre Bayer Web3 contacte a: jesusdelvalle@bayer.com o marianoel.sosa@bayer.com o maribel.rovetto@bayer.com.
With the aim of protecting more and more Greek patients, a new product in Cardiovascular Medicine is launched. KERENDIA is now available for patients with CKD & Type 2 Diabetes. Welcome to Bayer Hellas internal Kerendia launch event, focusing on educating & preparing the Sales Team for a successful product promotion in the Greek market. In this event, you familiarized yourselves with the promotional materials & the role plays. This is the first POAP related to a pharmaceutical product. If you received this POAP, you are a True Pioneer in the Web3 space. Bayer is proudly promoting innovative practices. https://www.bayer.com/en/poap-tc
What ever you do, do it with passion or et least with style! We in Medical Devices and eHealth stand for life changing combinations of medical devices together with our drugs. I´m proudly presenting the eHealth & Medical Software Solution team. Our joint vision is that every patient should get access to break trough eHealth solutions. Come and visit us - go/MDeH - or connect with me via Linkedin. Always keen to chat about "AI applied in med tech", "data mech in clinical practice", "if compliance and agility can coexist" & "how to get form a research hypothesis or concept to a data product"
I am a "Senior Insight Solutions Lead" which means that I work in DAIS team and try to generate novel insights for our R&D (and beyond) organization
